Patents by Inventor Stan Dysart

Stan Dysart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240399100
    Abstract: Provided herein are methods of reducing knee pain in a subject, the method including selecting an entry point of an injection needle in a subject's leg; inserting the injection needle into the needle entry point; advancing the tip of the injection needle to an injectate administration site; and administering a pharmaceutical composition at the injectate administration site; wherein the needle entry point is proximal to the adductor tubercle, and wherein the advancing the tip of the injection needle utilizes an angle of between approximately 10 and approximately 20 degrees medial to the axis of the femur and between approximately 40 degrees and 75 degrees posterior to the femur, wherein the needle is advanced between one inch and two inches, thereby reducing knee pain in a subject.
    Type: Application
    Filed: May 30, 2024
    Publication date: December 5, 2024
    Inventors: Stan Dysart, Jonathan H. Slonin, Jeffrey Gonzales
  • Patent number: 11918688
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Grant
    Filed: January 10, 2022
    Date of Patent: March 5, 2024
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • Patent number: 11819573
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Grant
    Filed: March 2, 2022
    Date of Patent: November 21, 2023
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • Patent number: 11813357
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Grant
    Filed: May 17, 2022
    Date of Patent: November 14, 2023
    Assignee: Pacira Pharmaceuticals, Inc.
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • Publication number: 20220273564
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Application
    Filed: May 17, 2022
    Publication date: September 1, 2022
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • Publication number: 20220218613
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Application
    Filed: March 2, 2022
    Publication date: July 14, 2022
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart
  • Publication number: 20220218610
    Abstract: In some embodiments provided herein is a method of treating hip pain in a subject, the method comprising administering into the subject a pharmaceutical composition comprising: a) a multivesicular liposome comprising: at least one amphipathic lipid, and at least one neutral lipid; and b) an aqueous phase comprising bupivacaine phosphate, wherein the aqueous phase is encapsulated within the multivesicular liposome.
    Type: Application
    Filed: January 10, 2022
    Publication date: July 14, 2022
    Inventors: Jonathan H. Slonin, Roy Winston, Stan Dysart